COVID-19
Why startups are investing thousands and thousands to make prescription drugs and semiconductors in house
In-area producing may audio like science fiction but it is going on previously, albeit on a very modest scale. It is really a fledgling market place that analysts and numerous startups are projecting will get off. “If you appear at pharma, semiconductors, splendor and health items and potentially foodstuff in the sense of like new […]
Read More
New Covid vaccines from Pfizer, Moderna and Novavax will likely protect against Eris variant
A pharmacist prepares to administer Covid-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center in Chicago, Illinois, Sept. 9, 2022. Scott Olson | Getty Images New Covid vaccines from Pfizer, Moderna and Novavax will likely provide protection against the new “Eris” variant, now the […]
Read More
Moderna shares rise on better Covid vaccine outlook despite sharp drop in sales
Artur Widak | Nurphoto | Getty Images Shares of Moderna rose Thursday after the biotech company hiked its full-year outlook for its Covid vaccine, its only marketable product, despite reporting a quarterly loss and sharp drop in revenue. Here are Moderna’s results: Loss per share: $3.62 (That may not be comparable to the $4.04 expected by […]
Read More
Airline ticket prices are ‘pretty a lot where by they will need to be,’ IATA suggests
ShareShare Short article by way of FacebookShare Article via TwitterShare Post by using LinkedInShare Posting through E-mail Conrad Clifford, deputy director standard of the Worldwide Air Transportation Affiliation, states “globally, ticket rates have risen fairly significantly in line with inflation.” Source
Read More
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal
Merck on Tuesday reported second-quarter revenue that topped expectations on strong sales of its blockbuster cancer drug Keytruda and HPV vaccine Gardasil. The pharmaceutical giant posted a quarterly loss, however, due to charges associated with the company’s acquisition of Prometheus Biosciences earlier this year. related investing news Merck swung to a net loss of $5.98 […]
Read More
Pfizer beats on earnings, but revenue misses as Covid product sales plummet
Pavlo Gonchar | Lightrocket | Getty Images Pfizer on Tuesday reported second-quarter adjusted earnings that topped Wall Street’s expectations, but posted revenue that fell short of estimates as Covid product sales plunged. Pfizer reported second-quarter sales of $12.73 billion, down 54% over the same period a year ago. Excluding sales of the company’s Covid vaccine […]
Read More
NIH to test Pfizer’s Paxlovid, other treatments as potential long Covid therapies
Paxlovid, Pfizer’s anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken October 7, 2022. Wolfgang Rattay | Reuters The National Institutes of Health said Monday it launched mid-stage clinical trials to test at least four treatments, including Pfizer‘s antiviral Covid-19 pill Paxlovid, as potential therapies for long Covid. There […]
Read More
New Covid vaccines are coming to the U.S. this fall, but uptake may be low — Here’s why
A pharmacist delivers a COVID-19 booster dose at a Chicago CVS store. Antonio Perez | Tribune News Service | Getty Images A new round of Covid vaccines is coming to the U.S. this fall — but many Americans may not roll up their sleeves and take one. That’s largely because pandemic fatigue, the belief that […]
Read More
China to resume 15-day visa-cost-free entry for citizens of Singapore and Brunei
Vacationers get there at the departure corridor in Singapore Changi airport in Singapore on March 31, 2023. Catherine Lai | Afp | Getty Images SINGAPORE — China will reinstate its 15-working day visa-free of charge entry for citizens of Singapore and Brunei from July 26, in accordance to the embassies of equally nations. This will […]
Read More